These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22512618)

  • 1. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
    Arikawa Y; Nishida H; Kurasawa O; Hasuoka A; Hirase K; Inatomi N; Hori Y; Matsukawa J; Imanishi A; Kondo M; Tarui N; Hamada T; Takagi T; Takeuchi T; Kajino M
    J Med Chem; 2012 May; 55(9):4446-56. PubMed ID: 22512618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening of potassium-competitive acid blockers.
    Kondo M; Kawamoto M; Hasuoka A; Kajino M; Inatomi N; Tarui N
    J Biomol Screen; 2012 Feb; 17(2):177-82. PubMed ID: 21940711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
    Hori Y; Imanishi A; Matsukawa J; Tsukimi Y; Nishida H; Arikawa Y; Hirase K; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2010 Oct; 335(1):231-8. PubMed ID: 20624992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).
    Shin JM; Inatomi N; Munson K; Strugatsky D; Tokhtaeva E; Vagin O; Sachs G
    J Pharmacol Exp Ther; 2011 Nov; 339(2):412-20. PubMed ID: 21828261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
    Nishida H; Hasuoka A; Arikawa Y; Kurasawa O; Hirase K; Inatomi N; Hori Y; Sato F; Tarui N; Imanishi A; Kondo M; Takagi T; Kajino M
    Bioorg Med Chem; 2012 Jun; 20(12):3925-38. PubMed ID: 22579619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands.
    Matsukawa J; Hori Y; Nishida H; Kajino M; Inatomi N
    Biochem Pharmacol; 2011 May; 81(9):1145-51. PubMed ID: 21371447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KFP-H008 blocks gastric acid secretion through inhibiting H
    Li CY; Su M; Yan YY; Zhou L; Ao LY; Fang WR; Li YM
    Eur J Pharmacol; 2017 Sep; 810():112-119. PubMed ID: 28629736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
    Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
    J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents.
    Sharma P; Singh S; Siddiqui TI; Singh VS; Kundu B; Prathipati P; Saxena AK; Dikshit DK; Rastogi L; Dixit C; Gupta MB; Patnaik GK; Dikshit M
    Eur J Med Chem; 2007 Mar; 42(3):386-93. PubMed ID: 17045703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action.
    Nishida H; Arikawa Y; Hirase K; Imaeda T; Inatomi N; Hori Y; Matsukawa J; Fujioka Y; Hamada T; Iida M; Nishitani M; Imanishi A; Fukui H; Itoh F; Kajino M
    Bioorg Med Chem; 2017 Jul; 25(13):3298-3314. PubMed ID: 28442261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion.
    Nishida H; Fujimori I; Arikawa Y; Hirase K; Ono K; Nakai K; Inatomi N; Hori Y; Matsukawa J; Fujioka Y; Imanishi A; Fukui H; Itoh F
    Bioorg Med Chem; 2017 Jul; 25(13):3447-3460. PubMed ID: 28483454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K; Carlsson E
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antigastric ulcer activity of novel 5-isoproyl-3,8-dimethylazulene derivatives.
    Zhang LY; Yang F; Shi WQ; Zhang P; Li Y; Yin SF
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5722-5. PubMed ID: 21885274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
    Shin JM; Cho YM; Sachs G
    J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrimidines as acid pump antagonists (APAs).
    Yoon YA; Park CS; Cha MH; Choi H; Sim JY; Kim JG
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5735-8. PubMed ID: 20810280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations.
    Echizen H
    Clin Pharmacokinet; 2016 Apr; 55(4):409-18. PubMed ID: 26369775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.